Form 8-K - Current report:
SEC Accession No. 0000950170-25-012018
Filing Date
2025-02-03
Accepted
2025-02-03 07:05:44
Documents
16
Period of Report
2025-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250203.htm   iXBRL 8-K 60794
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 33658
3 EX-99.2 ivvd-ex99_2.htm EX-99.2 46500
4 GRAPHIC img59752938_0.jpg GRAPHIC 85687
5 GRAPHIC img60676459_0.jpg GRAPHIC 85687
6 GRAPHIC img60676459_1.jpg GRAPHIC 873059
  Complete submission text file 0000950170-25-012018.txt   1723528

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250203.xsd EX-101.SCH 31867
18 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250203_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 25580580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)